PET/CT在骨转移瘤冷冻消融后早期识别局部肿瘤进展中的效用
回顾性单机构研究纳入61例患者共80处骨转移灶,冷冻消融前后行PET/CT并计算SUVmax比值(病灶SUVmax与血池比值)。FDG组和11C-胆碱组出现局部肿瘤进展者,在首次及最远随访PET/CT上SUVmax比值均显著高于无进展者(p < 0.001)。结论认为消融后SUVmax比值升高应警惕局部肿瘤进展,与消融后时间无关。
要点
- 骨转移瘤冷冻消融后,局部进展组在首次及最远随访PET/CT上SUVmax比值均显著高于无进展组(p < 0.001)。
- FDG与11C-胆碱两种示踪剂均显示局部进展组SUVmax比值显著升高。
- 消融后SUVmax比值升高应警惕局部肿瘤进展,与消融后时间无关。
核心结论
- 骨转移瘤冷冻消融后SUVmax比值升高应警惕局部肿瘤进展,且与消融后时间无关。
研究设计与样本
- 回顾性单机构研究,纳入2007年9月至2015年7月间61例患者共80处骨转移灶,均接受冷冻消融并有消融前PET/CT及至少两次消融后PET/CT。
诊断标准与关键数值
- 计算每处骨转移灶消融前后的SUVmax比值(病灶SUVmax与血池比值),按消融后疾病状态(有无局部肿瘤进展)和示踪剂(11C-胆碱或18F-FDG)分组比较。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to evaluate the utility of combined PET/CT for the detection of early local tumor progression after cryoablation of bone metastases.
MATERIALS AND METHODS: A retrospective single-institution review revealed 61 consecutive patients with 80 separate bone metastases treated with cryoablation who were evaluated with a preablation PET/CT and at least two postablation PET/CT examinations between September 2007 and July 2015. Patients were excluded if they had local therapy or pathologic fracture after ablation. The patients were grouped according to postcryoablation disease status (i.e., local tumor progression or not) and PET radiotracer (i.e., 11C-choline or 18F-FDG) used. The maximum standardized uptake value (SUVmax) ratio (i.e., ratio of SUVmax to blood pool) was calculated within each osseous metastasis before and after cryoablation, and these were then compared between groups.
RESULTS: Of the 61 patients and 80 ablations performed, 32 patients were imaged with FDG PET/CT and 29 were imaged with 11C-choline PET/CT. Twenty-three patients imaged with FDG and 13 patients imaged with 11C-choline had evidence of local tumor progression on all postablation PET/CT examinations. The SUVmax ratio was significantly higher in patients with local tumor progression on the first and most remote postcryoablation PET/CT examinations for both FDG and 11C-choline (p < 0.001 in all cases). There was no significant difference in the postablation systemic therapy between the groups with and without local tumor progression.
CONCLUSION: Increased SUVmax ratio in patients after cryoablation for osseous metastatic disease should raise concern about local tumor progression independently of time after ablation.
引用
- Packard AT, Broski SM, Callstrom MR, et al. Utility of PET/CT After Cryoablation for Early Identification of Local Tumor Progression in Osseous Metastatic Disease. AJR Am J Roentgenol. 2017. PMID: 28333548. doi:10.2214/AJR.16.17222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。